MedTrace Logo

Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions

NCT01246505 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2012-07-12

No results posted yet for this study

Summary

Study of the BridgePoint Medical System in the crossing of chronic total occlusions of the lower extremities.

Conditions

  • Chronic Total Occlusion

Interventions

DEVICE

CTO Crossing and Percutaneous transluminal angioplasty

Crossing of the CTO with the BridgePoint Medical System and subsequent treatment of the CTO via PTA (specific devices to be used for PTA at investigators' discretion)

Sponsors & Collaborators

  • BridgePoint Medical

    lead INDUSTRY

Principal Investigators

  • William A Gray, MD · Columbia University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-12-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01246505 on ClinicalTrials.gov